Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123044002 | 12304400 | 2 | F | 20160304 | 20160716 | 20160426 | 20160729 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-115449 | RANBAXY | 61.00 | YR | M | Y | 78.00000 | KG | 20160729 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123044002 | 12304400 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, BID | 2000 | MG | N | U | 75747 | 500 | MG | Q12H | |||
| 123044002 | 12304400 | 2 | C | FERUMOXSIDE | 2 | Unknown | 20 MG, BID | U | U | 0 | 20 | MG | Q12H | ||||||
| 123044002 | 12304400 | 3 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | SLIDING SCALE BEFORE MEALS. | U | U | 0 | ||||||||
| 123044002 | 12304400 | 4 | C | LACTULOSE. | LACTULOSE | 1 | Unknown | 30 ML, TID | U | U | 0 | 30 | ML | Q8H | |||||
| 123044002 | 12304400 | 5 | C | RIFAXIMIN | RIFAXIMIN | 1 | Unknown | 500 MG, BID | U | U | 0 | 500 | MG | Q12H | |||||
| 123044002 | 12304400 | 6 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 50 MG, QD | U | U | 0 | 50 | MG | ||||||
| 123044002 | 12304400 | 7 | C | THIAMIN | THIAMINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 123044002 | 12304400 | 8 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123044002 | 12304400 | 1 | Hepatic encephalopathy |
| 123044002 | 12304400 | 2 | Product used for unknown indication |
| 123044002 | 12304400 | 3 | Product used for unknown indication |
| 123044002 | 12304400 | 4 | Product used for unknown indication |
| 123044002 | 12304400 | 5 | Product used for unknown indication |
| 123044002 | 12304400 | 6 | Product used for unknown indication |
| 123044002 | 12304400 | 7 | Product used for unknown indication |
| 123044002 | 12304400 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123044002 | 12304400 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123044002 | 12304400 | Joint swelling | |
| 123044002 | 12304400 | Pain in extremity | |
| 123044002 | 12304400 | Tendon rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123044002 | 12304400 | 1 | 20160302 | 20160304 | 0 |